Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2021-07-20 00:00:00 ET · period of report 2021-07-20 · accession 0001069530-21-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2021-07-20 | 2021-07-20 | FLNA | BARBIER REMI | Pres, CEO, Dir | M - OptEx | $20.23 | +2,801 | 326.7K | +0.9% | +$56.7K |
| DI | 2021-07-20 | 2021-07-20 | FLNA | BARBIER REMI | Pres, CEO, Dir | M - OptEx | $20.23 | -2,801 | 0 | -100% | -$56.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-20 | M | A | 2,801 | $20.23 | 326,652 | I By Family | — | — | (F1) Transaction represents exercise of stock options for cash. |
| 2 | Derivative | Common Stock | 2021-07-20 | M | D | 2,801 | $20.23 | 0 | I By Family | $20.23 · 2015-12-16 to 2021-12-16 | 2,801 Common Stock |